
Novo Nordisk halts Wegovy sales on Hims & Hers, claiming …
4 days ago · Novo Nordisk said it began selling Wegovy via telehealth companies, including Hims & Hers, after a nationwide shortage. In offering the drug through more retailers, Novo Nordisk …
Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy …
20 hours ago · Novo Nordisk is feuding with Hims & Hers Health over the latter's sale of compounded versions of Wegovy. Hims & Hers Health's business spans well beyond weight …
Hims & Hers' stock plunges. Here's why Wegovy parent ended its ...
4 days ago · Hims & Hers Health Inc.'s stock booked record losses Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration …
Hims & Hers stock drops 30% after Novo Nordisk terminates deal
5 days ago · Hims & Hers stock plunged around 30% on Monday after drugmaker Novo Nordisk abruptly ended a month-long collaboration to make its weight loss drug Wegovy available on …
Novo, Hims & Hers engage in war of words after Wegovy deal …
Hims & Hers CEO Andrew Dudum, in a post on X, accused Novo of attempting to control clinical standards at Hims & Hers to steer the company's patients toward Wegovy.
Novo Nordisk ends Wegovy deal with Hims & Hers - CNBC
5 days ago · Novo Nordisk said it is ending its collaboration with Hims & Hers due to concerns about the telehealth company's sales and promotion of cheaper knock-offs of the weight loss …
Novo Nordisk ends partnership with Hims & Hers over Wegovy …
4 days ago · The end of the collaboration means Hims will no longer be able to sell branded Wegovy drugs, and will no longer have direct access to Wegovy through the company’s …
Hims & Hers stock drops after Wegovy manufacturer ends deal to ...
5 days ago · Despite the halt, Hims & Hers stated earlier this month that it intends to continue selling "personalised" doses of Wegovy, priced from approximately $165 a month.
Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: …
4 days ago · Hims & Hers stock plunged nearly 35% on Monday following Novo Nordisk's announcement. This steep sell-off indicates how much the termination of the Wegovy deal …
Hims & Hers withdraws from Wegovy, Ozempic market
Feb 25, 2025 · Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S. Food and Drug Administration's declaration that …
- Some results have been removed